KIT and gastrointestinal stromal tumor: Genomic profiling of nearly 19,000 de-identified samples has shown c-kit alterations in 2.86% of 59 major cancer types studied, with some of them presenting very frequent and clinically actionable mutations [68], such as gastrointestinal stromal tumor (GIST) in about 80-85% of cases [69].